Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
PHASE2
This phase II trial tests how well etoposide, prednisone, vincristine, cycl...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
PHASE3
This phase III trial compares immunotherapy drugs (nivolumab or brentuximab...
Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
PHASE2
This phase II trial tests the effect of dose-adjusted etoposide, prednisone...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium